Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0760
G

Significant Medication Error: Insulin Overdose Due to Improper Administration

Haverhill, Massachusetts Survey Completed on 04-29-2025

Penalty

Fine: $10,868
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

A deficiency occurred when a resident with diabetes, who was prescribed Toujeo (a long-acting insulin) at a dose of 36 units daily via a pre-filled pen, was administered an incorrect dose. On the day of the incident, the assigned nurse was unable to locate the appropriate pen needles in the medication cart and, without seeking additional supplies or assistance, used a standard 100 unit/mL insulin syringe to draw up and inject 36 units from the Toujeo pen. This resulted in the resident receiving three times the prescribed dose, as Toujeo is concentrated at 300 units/mL, unlike standard insulin preparations. The error was discovered after the resident's blood sugar was found to be significantly low (52 mg/dL) during a routine check, and the resident subsequently developed symptoms of hypoglycemia, including pallor, sweating, cool and clammy skin, and malaise. The nurse had not verified the insulin concentration or the proper administration method as required by facility policy, and did not realize the risk of overdose when using a syringe with a different calibration than the pen device. The facility's policies clearly stated that insulin should be administered according to the physician's order and manufacturer instructions, which prohibit withdrawing Toujeo from the pen with a syringe due to the risk of overdose. The resident required treatment for hypoglycemia, including oral glucose, intravenous dextrose, and increased monitoring until blood sugar levels stabilized. Interviews confirmed that the nurse was familiar with the resident and the medication, but failed to follow proper procedures for insulin administration and did not check for available supplies elsewhere in the facility. The Director of Nursing confirmed that additional pen needles were available in the supply room at the time of the incident.

An unhandled error has occurred. Reload 🗙